Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 334,678 | 276,237 | 322,229 | 381,393 | 213,677 |
| Receivables | 21,052 | 10,877 | 3,879 | 1,637 | N/A |
| Inventories | 3,111 | 2,177 | 1,458 | 1,208 | 111 |
| TOTAL | $373,821 | $304,788 | $340,314 | $397,432 | $226,726 |
| Non-Current Assets | |||||
| PPE Net | 1,655 | 1,813 | 1,962 | 2,146 | 1,976 |
| Other Non-Current Assets | 11,568 | 12,775 | 14,223 | 14,264 | 8,290 |
| TOTAL | $13,223 | $14,588 | $16,185 | $16,410 | $10,266 |
| Total Assets | $387,044 | $319,376 | $356,499 | $413,842 | $236,992 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,133 | 7,656 | 8,403 | 12,601 | 5,794 |
| Accrued Expenses | 37,281 | 28,723 | 17,848 | 18,343 | 15,073 |
| Other current liabilities | 20,194 | 9,910 | 16,478 | 7,111 | 2,391 |
| TOTAL | $65,288 | $47,009 | $43,459 | $38,781 | $23,979 |
| Non-Current Liabilities | |||||
| Long Term Debt | 175,729 | 174,423 | 149,023 | 137,842 | 99,259 |
| Other Non-Current Liabilities | 333,139 | 331,773 | 312,520 | 309,978 | 131,527 |
| TOTAL | $508,868 | $506,196 | $461,543 | $447,820 | $230,786 |
| Total Liabilities | $574,156 | $553,205 | $505,002 | $486,601 | $254,765 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,377 | 59,594 | 58,535 | 58,477 | 57,253 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,188,560 | -1,102,983 | -1,011,537 | -928,685 | -849,115 |
| TOTAL | $-187,112 | $-233,829 | $-148,503 | $-72,759 | $-17,773 |
| Total Liabilities And Equity | $387,044 | $319,376 | $356,499 | $413,842 | $236,992 |